Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$392,144
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-11 Truitt Joseph Director Purchase +3,500 $2.80 $10K 6,250
2026-05-19 Truitt Joseph Director Grant or award · Stock Option (Right to Buy) +55,150 55,150
2025-05-13 Truitt Joseph Director Grant or award · Stock Option (Right to Buy) +19,000 19,000
2024-05-29 Truitt Joseph Director Grant or award · Stock Option (Right to Buy) +19,000 19,000
2023-05-17 Truitt Joseph Director Purchase +2,750 $3.73 $10K 2,750
2023-05-09 Truitt Joseph Director Grant or award · Stock Option (Right to Buy) +8,300 8,300
2022-05-10 Truitt Joseph Director Grant or award · Stock Option (Right to Buy) +8,300 8,300
2021-05-12 Truitt Joseph Director Grant or award · Stock Option (right to buy) +8,300 8,300
2020-09-29 Truitt Joseph Director Grant or award · Stock Option (right to buy) +16,600 16,600

Page 1 of 1 · 9 trades